These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17506147)

  • 1. Drug-resistant gonorrhoeae spread in the USA.
    McCarthy M
    Lancet; 2007 May; 369(9573):1592. PubMed ID: 17506147
    [No Abstract]   [Full Text] [Related]  

  • 2. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men--United States, 2003, and revised recommendations for gonorrhea treatment, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(16):335-8. PubMed ID: 15123985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Ophthalmia Venerea": A dreadful complication of fluoroquinolone-resistant Neisseria gonorrhoeae.
    Guerrero ML; Alfaro IJ; Sandoval BG; Górgolas M
    Sex Transm Dis; 2010 May; 37(5):340-1. PubMed ID: 20429088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What management is there for gonorrhea in the postquinolone era?
    Tapsall JW
    Sex Transm Dis; 2006 Jan; 33(1):8-10. PubMed ID: 16385215
    [No Abstract]   [Full Text] [Related]  

  • 5. Practice alert: CDC no longer recommends quinolones for treatment of gonorrhea.
    Campos-Outcalt D
    J Fam Pract; 2007 Jul; 56(7):554-8. PubMed ID: 17605948
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluoroquinolone-resistant Neisseria gonorrhoeae: the inevitable epidemic.
    Ghanem KG; Giles JA; Zenilman JM
    Infect Dis Clin North Am; 2005 Jun; 19(2):351-65. PubMed ID: 15963876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resistance of Russian isolates of Neisseria gonorrhoeae to fluoroquinolones].
    Vereshchagin VA; Il'una EN; Malakhova MV; Zubkov MM; Sidorenko SV; Kubanova AA; Govorun VM
    Mol Gen Mikrobiol Virusol; 2005; (1):23-7. PubMed ID: 15790029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone resistance in Neisseria gonorrhoeae--Colorado and Washington, 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Oct; 44(41):761-4. PubMed ID: 7565558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Apr; 56(14):332-6. PubMed ID: 17431378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence and spread of drug resistant Neisseria gonorrhoeae.
    Deguchi T; Nakane K; Yasuda M; Maeda S
    J Urol; 2010 Sep; 184(3):851-8; quiz 1235. PubMed ID: 20643433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neisseria gonorrhoeae - Rising Infection Rates, Dwindling Treatment Options.
    Blank S; Daskalakis DC
    N Engl J Med; 2018 Nov; 379(19):1795-1797. PubMed ID: 30403946
    [No Abstract]   [Full Text] [Related]  

  • 12. The epidemiology of fluoroquinolone-resistant Neisseria gonorrhoeae in Hawaii, 2001.
    Newman LM; Wang SA; Ohye RG; O'Connor N; Lee MV; Weinstock HS
    Clin Infect Dis; 2004 Mar; 38(5):649-54. PubMed ID: 14986248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDC update on gonorrhea: expand treatment to limit resistance.
    Campos-Outcalt D
    J Fam Pract; 2011 Dec; 60(12):736-40. PubMed ID: 22163356
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluoroquinolone resistance in Neisseria gonorrhoeae.
    Knapp JS; Fox KK; Trees DL; Whittington WL
    Emerg Infect Dis; 1997; 3(1):33-9. PubMed ID: 9126442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003.
    Bauer HM; Mark KE; Samuel M; Wang SA; Weismuller P; Moore D; Gunn RA; Peter C; Vannier A; DeAugustine N; Klausner JD; Knapp JS; Bolan G
    Clin Infect Dis; 2005 Sep; 41(6):795-803. PubMed ID: 16107976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The rise in fluoroquinolone-resistant Neisseria gonorrhoeae among people attending the Municipal Health Service's clinic for sexually transmitted diseases in Amsterdam, the Netherlands; cefotaxime now first-choice treatment for uncomplicated gonorrhoea].
    Kolader M; Peerbooms PG; Vader PC; van Bergen JE; Fennema JS; de Vries HJ
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2129-32. PubMed ID: 15553358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(46):1041-4. PubMed ID: 12487525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of multidrug-resistant Neisseria gonorrhoeae strains circulating worldwide.
    Tanaka M
    Int J Urol; 2012 Feb; 19(2):98-9. PubMed ID: 22168311
    [No Abstract]   [Full Text] [Related]  

  • 19. The prevalence and antibiotics susceptibility pattern of Neisseria gonorrhoeae in patients attending OPD clinics at St. Mary's Hospital Lacor Uganda.
    Amito Florence P; Otim F; Okongo F; Ogwang M; Greco D
    J Prev Med Hyg; 2012 Dec; 53(4):186-9. PubMed ID: 23469585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone-resistant Neisseria gonorrhoeae--San Diego, California, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 May; 47(20):405-8. PubMed ID: 9622458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.